Constantine Davides
Stock Analyst at Citizens
(1.04)
# 3,895
Out of 5,116 analysts
116
Total ratings
30.84%
Success rate
-20.65%
Average return
Main Sectors:
Stocks Rated by Constantine Davides
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AMN AMN Healthcare Services | Maintains: Market Outperform | $24 → $22 | $16.10 | +36.65% | 13 | Dec 19, 2025 | |
| HQY HealthEquity | Maintains: Market Outperform | $117 → $122 | $93.48 | +30.51% | 6 | Dec 4, 2025 | |
| EVH Evolent Health | Maintains: Market Outperform | $13 → $11 | $4.12 | +166.99% | 11 | Nov 10, 2025 | |
| PRVA Privia Health Group | Maintains: Market Outperform | $30 → $31 | $24.13 | +28.47% | 5 | Nov 7, 2025 | |
| OPRX OptimizeRx | Maintains: Market Outperform | $23 → $24 | $12.48 | +92.31% | 11 | Nov 7, 2025 | |
| OPCH Option Care Health | Maintains: Market Outperform | $38 → $36 | $32.58 | +10.50% | 7 | Oct 31, 2025 | |
| WAY Waystar Holding | Initiates: Market Outperform | $48 | $32.98 | +45.54% | 1 | Sep 18, 2025 | |
| ADUS Addus HomeCare | Reiterates: Market Outperform | $150 | $110.16 | +36.17% | 4 | Jul 16, 2025 | |
| SLP Simulations Plus | Reiterates: Market Perform | n/a | $18.76 | - | 2 | Jun 18, 2025 | |
| CERT Certara | Reiterates: Market Perform | n/a | $8.89 | - | 3 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Market Perform | n/a | $0.73 | - | 4 | Apr 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Market Outperform | $113 | $81.00 | +39.51% | 2 | Apr 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Outperform | $20 → $26 | $32.80 | -20.73% | 1 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Outperform | $225 → $248 | $176.41 | +40.58% | 1 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Market Perform | n/a | $23.61 | - | 2 | Feb 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Market Perform | n/a | $8.00 | - | 2 | Feb 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $25.80 | - | 3 | Sep 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $5.25 | $1.19 | +341.18% | 3 | Jun 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $125 | $0.53 | +23,374.18% | 5 | May 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $28.50 | -47.37% | 3 | May 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $23 | $19.80 | +13.64% | 4 | May 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $8.5 | $3.04 | +179.61% | 2 | May 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $14 | $1.01 | +1,286.14% | 4 | Apr 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $360 | $1.42 | +25,252.11% | 4 | Apr 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $3,240 | $1.70 | +190,488.24% | 3 | Apr 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $46 → $40 | $1.12 | +3,471.43% | 2 | Apr 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $6 | $0.25 | +2,300.00% | 2 | Mar 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $1,400 → $800 | $1.21 | +66,015.70% | 2 | Sep 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9,960 → $4,980 | $1.15 | +432,943.48% | 2 | Sep 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $110 → $85 | $0.38 | +22,151.31% | 2 | Sep 23, 2022 |
AMN Healthcare Services
Dec 19, 2025
Maintains: Market Outperform
Price Target: $24 → $22
Current: $16.10
Upside: +36.65%
HealthEquity
Dec 4, 2025
Maintains: Market Outperform
Price Target: $117 → $122
Current: $93.48
Upside: +30.51%
Evolent Health
Nov 10, 2025
Maintains: Market Outperform
Price Target: $13 → $11
Current: $4.12
Upside: +166.99%
Privia Health Group
Nov 7, 2025
Maintains: Market Outperform
Price Target: $30 → $31
Current: $24.13
Upside: +28.47%
OptimizeRx
Nov 7, 2025
Maintains: Market Outperform
Price Target: $23 → $24
Current: $12.48
Upside: +92.31%
Option Care Health
Oct 31, 2025
Maintains: Market Outperform
Price Target: $38 → $36
Current: $32.58
Upside: +10.50%
Waystar Holding
Sep 18, 2025
Initiates: Market Outperform
Price Target: $48
Current: $32.98
Upside: +45.54%
Addus HomeCare
Jul 16, 2025
Reiterates: Market Outperform
Price Target: $150
Current: $110.16
Upside: +36.17%
Simulations Plus
Jun 18, 2025
Reiterates: Market Perform
Price Target: n/a
Current: $18.76
Upside: -
Certara
May 6, 2025
Reiterates: Market Perform
Price Target: n/a
Current: $8.89
Upside: -
Apr 28, 2025
Reiterates: Market Perform
Price Target: n/a
Current: $0.73
Upside: -
Apr 22, 2025
Reiterates: Market Outperform
Price Target: $113
Current: $81.00
Upside: +39.51%
Feb 26, 2025
Maintains: Market Outperform
Price Target: $20 → $26
Current: $32.80
Upside: -20.73%
Feb 26, 2025
Maintains: Market Outperform
Price Target: $225 → $248
Current: $176.41
Upside: +40.58%
Feb 6, 2025
Reiterates: Market Perform
Price Target: n/a
Current: $23.61
Upside: -
Feb 6, 2025
Reiterates: Market Perform
Price Target: n/a
Current: $8.00
Upside: -
Sep 19, 2024
Downgrades: Market Perform
Price Target: n/a
Current: $25.80
Upside: -
Jun 1, 2023
Assumes: Buy
Price Target: $5.25
Current: $1.19
Upside: +341.18%
May 16, 2023
Reiterates: Buy
Price Target: $125
Current: $0.53
Upside: +23,374.18%
May 11, 2023
Reiterates: Buy
Price Target: $15
Current: $28.50
Upside: -47.37%
May 10, 2023
Reiterates: Buy
Price Target: $23
Current: $19.80
Upside: +13.64%
May 5, 2023
Reiterates: Buy
Price Target: $8.5
Current: $3.04
Upside: +179.61%
Apr 27, 2023
Reiterates: Buy
Price Target: $14
Current: $1.01
Upside: +1,286.14%
Apr 19, 2023
Reiterates: Buy
Price Target: $360
Current: $1.42
Upside: +25,252.11%
Apr 13, 2023
Reiterates: Buy
Price Target: $3,240
Current: $1.70
Upside: +190,488.24%
Apr 3, 2023
Maintains: Buy
Price Target: $46 → $40
Current: $1.12
Upside: +3,471.43%
Mar 16, 2023
Reiterates: Buy
Price Target: $6
Current: $0.25
Upside: +2,300.00%
Sep 28, 2022
Maintains: Buy
Price Target: $1,400 → $800
Current: $1.21
Upside: +66,015.70%
Sep 28, 2022
Maintains: Buy
Price Target: $9,960 → $4,980
Current: $1.15
Upside: +432,943.48%
Sep 23, 2022
Maintains: Buy
Price Target: $110 → $85
Current: $0.38
Upside: +22,151.31%